Fentanest


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 37.8%
Sedation 8.3%
General Anaesthesia 7.2%
Anaesthesia 5.8%
Epidural Anaesthesia 5.5%
Vitamin Supplementation 5.0%
Hypertension 3.6%
Anaesthesia Procedure 3.3%
Diuretic Therapy 3.3%
Mineral Supplementation 3.3%
Analgesic Effect 2.2%
Immunosuppressant Drug Therapy 2.2%
Postoperative Analgesia 2.2%
Airway Burns 1.7%
Induction And Maintenance Of Anaesthesia 1.7%
Knee Arthroplasty 1.7%
Muscle Relaxant Therapy 1.7%
Premedication 1.4%
Anaesthetic Premedication 1.1%
Blood Pressure Increased 1.1%
Toxic Epidermal Necrolysis 17.1%
Pulmonary Infarction 11.4%
Nausea 8.6%
Cardiac Arrest 5.7%
Laryngeal Oedema 5.7%
Post Procedural Complication 5.7%
Ventricular Fibrillation 5.7%
White Blood Cell Count Decreased 5.7%
Delayed Recovery From Anaesthesia 2.9%
Hypotension 2.9%
Liver Disorder 2.9%
Muscle Rigidity 2.9%
Neuroleptic Malignant Syndrome 2.9%
Platelet Count Decreased 2.9%
Po2 Decreased 2.9%
Pruritus Generalised 2.9%
Right Ventricular Failure 2.9%
Splenomegaly 2.9%
Status Asthmaticus 2.9%
Tongue Oedema 2.9%
Concomitant
Drug Use For Unknown Indication 16.6%
Anaesthesia 12.5%
Induction Of Anaesthesia 7.4%
Prophylaxis 6.0%
Maintenance Of Anaesthesia 5.7%
General Anaesthesia 4.9%
Sedation 4.9%
Analgesic Therapy 4.6%
Hypotonia 4.6%
Analgesic Effect 4.0%
Epidural Anaesthesia 4.0%
Pain 4.0%
Premedication 4.0%
Surgery 3.3%
Induction And Maintenance Of Anaesthesia 2.7%
Infection Prophylaxis 2.5%
Hypertension 2.2%
Local Anaesthesia 2.2%
Blood Pressure Management 2.1%
Metastatic Pain 1.9%
Shock 10.3%
Pyrexia 7.4%
Sinus Tachycardia 7.4%
Rash 5.9%
Rhabdomyolysis 5.9%
Ventricular Tachycardia 5.9%
White Blood Cell Count Decreased 5.9%
Convulsion 4.4%
Delayed Recovery From Anaesthesia 4.4%
Drug Withdrawal Syndrome 4.4%
Liver Disorder 4.4%
Post Procedural Complication 4.4%
Tachycardia 4.4%
Threatened Labour 4.4%
Vomiting 4.4%
White Blood Cell Count Increased 4.4%
Altered State Of Consciousness 2.9%
Cardiac Arrest 2.9%
Chromaturia 2.9%
Disseminated Intravascular Coagulation 2.9%

Drug Data